SCHEMBL29792811

SCHEMBL29792811

COc1ccc(NC(=O)C(F)(F)F)cc1F

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.77
CYP2C9 P11712 1/20 0.77
CYP2C19 P33261 1/20 0.77
EPHX2 P34913 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.50
IDO1 P14902 1/20 0.49
TDO2 P48775 1/20 0.49
RAB9A P51151 4/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
GAA P10253 2/20 0.48
NAMPT P43490 1/20 0.47
MAPT P10636 3/20 0.47
NPC1 O15118 2/20 0.47
KCNQ3 O43525 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23088434 1.00 CYP1A2 (0.77) CYP1A2CYP2C9CYP2C19EPHX2L3MBTL1
SCHEMBL4440336 0.87 CYP1A2 (1.00) CYP1A2CYP2C9CYP2C19L3MBTL1RAB9A
SCHEMBL9823917 0.84 CYP1A2 (0.77) CYP1A2CYP2C9CYP2C19L3MBTL1IDO1
SCHEMBL7871733 0.83 CYP1A2 (0.75) CYP1A2CYP2C9CYP2C19L3MBTL1IDO1
SCHEMBL13881965 0.83 CYP2C9 (0.75) CYP1A2CYP2C9CYP2C19L3MBTL1IDO1
SCHEMBL13434123 0.82 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19EPHX2L3MBTL1
SCHEMBL2192767 0.82 ALDH1A1 (0.60) CYP1A2CYP2C9CYP2C19EPHX2RAB9A
SCHEMBL3926310 0.82 SMN1; SMN2 (0.54) CYP1A2CYP2C9CYP2C19EPHX2RAB9A
SCHEMBL6422179 0.82 CYP1A2 (0.73) CYP1A2CYP2C9CYP2C19L3MBTL1IDO1
SCHEMBL20646201 0.81 CYP1A2 (0.77) CYP1A2CYP2C9CYP2C19L3MBTL1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031547-A1 PLASMA KALLIKREIN INHIBITORS AND USES THEREOF Takeda Pharmaceutical Company Limited (JP) 2022-07-27 EP disclosed